IMO, FDA played dirty on EGRX with EHS indication, EGRX should drop its pursuit of EHS indication, and spend money on other big indications, EHS should be used off-label when other indication are approved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.